Prof. Kayla N. Green: The progress of cancer treatment is currently determined using imaging techniques, requiring an infusion of contrast agents to visualize tumor sizes. Such screening can only safely be done about every six weeks. Prof. Green’s research group is looking for a better way. They are developing electrochemical biosensors that can detect and monitor biomolecules associated with disease, particularly cancer. Their method holds promise as a way to provide earlier treatment regimens, with more frequent and less burdensome screenings. Ultimately Green aims to provide a cheap, fast, reliable screening method to detect biomolecules that are elevated in blood, urine, or saliva when cancer cells are growing. Preliminary results have been encouraging. The project is funded by a grant from The Welch Foundation.
Prof. Kayla N. Green
Comments are closed.